Invesco
AMED

Invesco’s Amedisys AMED Stock Holding History

Invesco’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-96,632
Closed -$9.51M – 3787
2025
Q2 		$9.51M Buy
96,632
+1,317
+1% +$125K ﹤0.01% 1805
2025
Q1 		$8.83M Buy
95,315
+4,468
+5% +$412K ﹤0.01% 1850
2024
Q4 		$8.25M Buy
90,847
+4,942
+6% +$454K ﹤0.01% 1970
2024
Q3 		$8.29M Sell
85,905
-45,685
-35% -$4.46M ﹤0.01% 1944
2024
Q2 		$12.1M Sell
131,590
-45,194
-26% -$4.19M ﹤0.01% 1696
2024
Q1 		$16.3M Buy
176,784
+98,929
+127% +$9.27M ﹤0.01% 1547
2023
Q4 		$7.4M Buy
77,855
+391
+0.5% +$36.5K ﹤0.01% 2015
2023
Q3 		$7.24M Sell
77,464
-5,214
-6% -$482K ﹤0.01% 1978
2023
Q2 		$7.56M Sell
82,678
-2,458
-3% -$202K ﹤0.01% 2005
2023
Q1 		$6.26M Sell
85,136
-24,173
-22% -$2.09M ﹤0.01% 2107
2022
Q4 		$9.13M Buy
109,309
+42,547
+64% +$3.84M ﹤0.01% 1910
2022
Q3 		$6.46M Sell
66,762
-5,801
-8% -$692K ﹤0.01% 2062
2022
Q2 		$7.63M Sell
72,563
-268,378
-79% -$34.3M ﹤0.01% 2028
2022
Q1 		$58.7M Buy
340,941
+16,892
+5% +$2.52M 0.02% 946
2021
Q4 		$52.5M Sell
324,049
-107,174
-25% -$17.2M 0.01% 1022
2021
Q3 		$64.3M Sell
431,223
-392,859
-48% -$81.7M 0.02% 954
2021
Q2 		$202M Sell
824,082
-99,859
-11% -$26.2M 0.05% 521
2021
Q1 		$245M Sell
923,941
-19,293
-2% -$5.44M 0.07% 382
2020
Q4 		$277M Buy
943,234
+368,694
+64% +$94.5M 0.08% 307
2020
Q3 		$136M Buy
574,540
+227,573
+66% +$51.7M 0.05% 508
2020
Q2 		$68.9M Sell
346,967
-110,172
-24% -$20.5M 0.02% 768
2020
Q1 		$83.9M Buy
457,139
+36,327
+9% +$6.46M 0.04% 570
2019
Q4 		$70.2M Buy
420,812
+51,959
+14% +$7.73M 0.02% 838
2019
Q3 		$48.3M Sell
368,853
-8,343
-2% -$1.09M 0.01% 1011
2019
Q2 		$45.8M Buy
377,196
+20,029
+6% +$2.38M 0.01% 1068
2019
Q1 		$44M Sell
357,167
-97,641
-21% -$12.3M 0.01% 869
2018
Q4 		$53.3M Sell
454,808
-105,889
-19% -$12.5M 0.02% 735
2018
Q3 		$70.1M Buy
560,697
+218,920
+64% +$24.2M 0.02% 704
2018
Q2 		$29.2M Buy
341,777
+199,746
+141% +$14.7M 0.01% 1042
2018
Q1 		$8.57M Buy
142,031
+36,490
+35% +$2.08M ﹤0.01% 1642
2017
Q4 		$5.56M Sell
105,541
-44,394
-30% -$2.34M ﹤0.01% 1915
2017
Q3 		$8.39M Buy
149,935
+39,827
+36% +$2.11M ﹤0.01% 1668
2017
Q2 		$6.92M Buy
110,108
+20,850
+23% +$1.21M ﹤0.01% 1760
2017
Q1 		$4.56M Sell
89,258
-29,340
-25% -$1.4M ﹤0.01% 2054
2016
Q4 		$5.06M Sell
118,598
-50,716
-30% -$2.16M ﹤0.01% 1973
2016
Q3 		$8.03M Buy
169,314
+3,590
+2% +$179K ﹤0.01% 1651
2016
Q2 		$8.37M Buy
165,724
+23,229
+16% +$1.17M ﹤0.01% 1542
2016
Q1 		$6.89M Sell
142,495
-122,013
-46% -$4.71M ﹤0.01% 1624
2015
Q4 		$10.4M Sell
264,508
-5,098
-2% -$204K ﹤0.01% 1472
2015
Q3 		$10.2M Buy
269,606
+57,145
+27% +$2.41M ﹤0.01% 1455
2015
Q2 		$8.44M Buy
212,461
+38,905
+22% +$1.21M ﹤0.01% 1639
2015
Q1 		$4.65M Sell
173,556
-44,364
-20% -$1.25M ﹤0.01% 2026
2014
Q4 		$6.4M Buy
217,920
+13,980
+7% +$345K ﹤0.01% 1748
2014
Q3 		$4.11M Buy
203,940
+29,857
+17% +$576K ﹤0.01% 2071
2014
Q2 		$2.91M Sell
174,083
-25,552
-13% -$362K ﹤0.01% 2345
2014
Q1 		$2.97M Sell
199,635
-15,398
-7% -$237K ﹤0.01% 2295
2013
Q4 		$3.15M Sell
215,033
-88,162
-29% -$1.42M ﹤0.01% 2345
2013
Q3 		$5.22M Buy
303,195
+129,073
+74% +$1.91M ﹤0.01% 1896
2013
Q2 		$2.02M Buy
+174,122
New +$1.99M ﹤0.01% 2385

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Invesco's AMED Position: Q3 2025 in Review

Invesco sold out of Amedisys (AMED) in Q3 2025, closing a stake of 96,632 shares — an estimated $9.51M sold.

Invesco first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $277M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Invesco reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Invesco sold 96,632 Amedisys shares in Q3 2025, an estimated $9.51M.
  • Invesco first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Invesco's Amedisys position peaked at $277M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Invesco's 13F filing for Q3 2025, filed 13 Nov 2025.